Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 2, Number 1, February 2010, pages 34-38

Prevalence and Immunization Status of Hepatitis B Virus in the HIV Cohort in Fife, Scotland

Tables

Table 1. Variables of HIV Cohort in Fife
 
Characteristic of VariableResults
Age in years:
Mean (range)		42.6 (20 - 46)
Nadir CD4:
Mean (range) cells/mm3		174 (0 - 673)
CD4 cell count at the time of HBV testing:
Mean (range) cells/mm3		409 (52 - 1074)
HIV RNA level at the time of HBV testing:
Mean (range) copies/ml		29012.0
(< 40 - 1000000)
HCV antibody positivity9 (12.9%)
HCV RNA positivity8 (11.2 %)
Current HBV infection/carrier
(HBsAg positive, anti-HBc positive)		2 (2.8%)
Past exposure to HBV
(HBsAg negative, anti-HBc positive)		16 (22.9%)
Occult HBV infection
(HBsAg negative, anti-HBc positive, HBV DNA positive)		2 (2.8%)
Positive history for HBV immunisation17 (24.2%)
Detectable Anti-HBs in immunised patients12 (70.6%)
ALT level on HBsAg positive, anti-HBc
positive patients: Mean (range) IU/ml		32.6 (10 - 111)
Patients with positive HBV serum markers
currently receiving TDF/3TC/FTC regimes		14 (77.8%)

 

Table 2. HBV Vaccination Status and Antibody Response in the HIV Cohort in Fife
 
CategoryVaccination StatusAntibody Response
> 100 IU/l< 100 IU/lNot tested
MSM
n = 22 (31%)		Vaccinated: 9 (41%)
Not vaccinated: 13 (59%)		5 (56%)2 (22%)2 (22%)
Others
n = 48 (69%)		Vaccinated: 8 (17%)
Not vaccinated: 40 (83%)		2 (25%)3 (37.5)3 (37.5%)